Concerta is the brand name for an extended-release formulation of methylphenidate, a central nervous system stimulant widely prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and, in some cases, narcolepsy. Approved by regulatory agencies including the FDA, EMA, Health Canada, MHRA, and TGA, Concerta utilizes an advanced osmotic-controlled release oral delivery system (OROS) […]